drugset / Trial / NCT02059785
Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke
RandomizedParallel-groupTriple-blindTreatment
Summary
This research is a Randomized, double-blind, placebo-controlled, multicenter clinical study. Chinese subjects with Ischemic Stroke.
Timeline
- Start
- 2013-06
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pinocembrin | Small molecule | 40 mg | Intravenous |
| Subject | Pinocembrin | Small molecule | 60 mg | Intravenous |